The search for value : measuring the company`s cost of capital /

Por Ehrhardt, Michael C.
Publicado em 1994

Administração financeira : teoria e prática /

Por Ehrhardt, Michael C, Brigham, Eugene F
Publicado em 2012

Administração financeira : teoria e prática /

Por Brigham, Eugene F., Ehrhardt, Michael C.
Publicado em 2006

Combination of MEK and SRC inhibition suppresses melanoma cell growth and invasion

Por Ferguson, Jennifer, Arozarena, Imanol, Ehrhardt, Michael, Wellbrock, Claudia
Publicado em 2012

Simultaneously double infection of oncolytic viruses leads to addition of cell death induction in glioblastoma cell lines

Por Ehrhardt, Michael, Frank, Julia, Smola, Sigrun, Graf, Norbert
Publicado no Mol Cell Pediatr (2015)

Financial management : theory and practice /

Por Brigham, Eugene F., Gapenski, Louis C., Ehrhardt, Michael C.
Publicado em 1999

Administração financeira : teoria e prática /

Por Brigham, Eugene F., Gapenski, Louis C., Ehrhardt, Michael C.
Publicado em 2001

In comparative analysis of multi-kinase inhibitors for targeted medulloblastoma therapy pazopanib exhibits promising in vitro and in vivo efficacy

Por Craveiro, Rogerio B., Ehrhardt, Michael, Holst, Martin I., Pietsch, Thorsten, Dilloo, Dagmar
Publicado em 2014

The PI3K inhibitor GDC-0941 displays promising in vitro and in vivo efficacy for targeted medulloblastoma therapy

Por Ehrhardt, Michael, Craveiro, Rogerio B., Holst, Martin I., Pietsch, Torsten, Dilloo, Dagmar
Publicado no Oncotarget (2014)

The anti-neoplastic activity of Vandetanib against high-risk medulloblastoma variants is profoundly enhanced by additional PI3K inhibition

Por Craveiro, Rogerio B, Ehrhardt, Michael, Velz, Julia, Olschewski, Martin, Goetz, Barbara, Pietsch, Torsten, Dilloo, Dagmar
Publicado no Oncotarget (2017)

Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients

Por Taylor, Patricia A., Ehrhardt, Michael J., Roforth, Matthew M., Swedin, Jessica M., Panoskaltsis-Mortari, Angela, Serody, Jonathan S., Blazar, Bruce R.
Publicado em 2007

Insights into the mechanism of FTY720 and compatibility with regulatory T cells for the inhibition of graft-versus-host disease (GVHD)

Por Taylor, Patricia A., Ehrhardt, Michael J., Lees, Christopher J., Tolar, Jakub, Weigel, Brenda J., Panoskaltsis-Mortari, Angela, Serody, Jonathan S., Brinkmann, Volker, Blazar, Bruce R.
Publicado em 2007

MSC Therapy Attenuates Obliterative Bronchiolitis after Murine Bone Marrow Transplant

Por Raza, Kashif, Larsen, Trevor, Samaratunga, Nath, Price, Andrew P., Meyer, Carolyn, Matson, Amy, Ehrhardt, Michael J., Fogas, Samuel, Tolar, Jakub, Hertz, Marshall I., Panoskaltsis-Mortari, Angela
Publicado em 2014

TLR agonists regulate alloresponses and uncover a critical role for donor APCs in allogeneic bone marrow rejection

Por Taylor, Patricia A., Ehrhardt, Michael J., Lees, Christopher J., Panoskaltsis-Mortari, Angela, Krieg, Arthur M., Sharpe, Arlene H., Murphy, William J., Serody, Jonathan S., Hemmi, Hiroaki, Akira, Shizuo, Levy, Robert B., Blazar, Bruce R.
Publicado em 2008

Early assessment of dosimetric and biological differences of total marrow irradiation versus total body irradiation in rodents

Por Hui, Susanta, Takahashi, Yutaka, Holtan, Shernan G., Azimi, Rezvan, Seelig, Davis, Yagi, Masashi, Ingvalson, Jessie, Alaei, Parham, Sharkey, Leslie, Kodal, Behiye, Peterson, Nicholas, Meyer, Carolyn, Godin, Lindsey, Ehrhardt, Michael, Storme, Guy, Zhou, Daohong, Panoskaltsis-Mortari, Angela
Publicado no Radiother Oncol (2017)